Tom Heyman
Executive Partner @ Bioqube Ventures
New Brunswick, United States
Tom Heyman is a startup investor at Bioqube Ventures in New Brunswick. Tom J. Heyman is based out of Newtown, Pennsylvania, and is the Executive Partner of Bioqube Ventures and Board of Director of SynOx Therapeutics and Board Member of Exelixis, Legend Biotech, Akero Therapeutics, and imec. Tom previously worked at Johnson & Johnson as a President. Tom J. Heyman attended KU Leuven.
Last updated:
For AI agents: llms.txt
About Bioqube Ventures
Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.
Bioqube Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Debbie Dumont
Co-founder and Managing Partner
|
|||
Debora Dumont
Co-Founder & Managing Partner
|
|||
Dirk Reyn
Managing Partner
|
|||
Nico Vandervelpen
Co-founder and Managing Partner
|
|||
|
Tom Heyman
Executive Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
